Evidence map›Paper›PMID 35701535›Full record

ArticleOncogene2022

Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling.

Zhuoxian Rong, Lu Zhang, Zhi Li, Zhi Xiao, Yumei Duan, Xinxin Ren, Yuyuan Zi, Jie Gao, Yun Mu, Yidi Guan and 15 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Zhuoxian RongXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Lu ZhangXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhi LiXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhi XiaoDepartment of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yumei DuanDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Xinxin RenXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yuyuan ZiXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Jie GaoXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yun MuXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yidi GuanXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhen CaoXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Xitao WangXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Qian PeiXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yu ZengXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Qi FanXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zimei ZengXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Danmin OuXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Jiang HeXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yingjie NieNHC Key Laboratory of Pulmonary Immune-Related Diseases, Guizhou Provincial People's Hospital, Guiyang, 550000, China.
Rong TanXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Liang WengXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.ORCID http://orcid.org/0000-0001-7058-8274
Yuhao LiCollege of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China.
Rong XiangCollege of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China.ORCID http://orcid.org/0000-0003-3487-7348
Yuezhen DengXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. yuezhendeng@csu.edu.cn.ORCID http://orcid.org/0000-0002-8342-126X
Lunquan SunXiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. lunquansun@csu.edu.cn.ORCID http://orcid.org/0000-0002-0558-5250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35701535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.